We just received data on a new analyst forecast for $VRTX. Greg Harrison from Scotiabank set a price target of 442.0 for VRTX.
To track analyst ratings and price targets for $VRTX, check out Quiver Quantitative's $VRTX forecast page.
$VRTX Price Targets
Multiple analysts have issued price targets for $VRTX recently. We have seen 7 analysts offer price targets for $VRTX in the last 6 months, with a median target of $460.0.
Here are some recent targets:
- Greg Harrison from Scotiabank set a target price of $442.0 on 05/06/2025
- An analyst from Cantor Fitzgerald set a target price of $535.0 on 04/22/2025
- Evan Seigerman from BMO Capital set a target price of $545.0 on 01/31/2025
- Mohit Bansal from Wells Fargo set a target price of $460.0 on 01/30/2025
- Terence Flynn from Morgan Stanley set a target price of $456.0 on 01/10/2025
- Brian Abrahams from RBC Capital set a target price of $400.0 on 12/19/2024
- Michael Yee from Jefferies set a target price of $550.0 on 12/09/2024
$VRTX Congressional Stock Trading
Members of Congress have traded $VRTX stock 4 times in the past 6 months. Of those trades, 2 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $VRTX stock by members of Congress over the last 6 months:
- REPRESENTATIVE BYRON DONALDS has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 03/20.
- REPRESENTATIVE JEFFERSON SHREVE has traded it 2 times. They made 2 purchases worth up to $100,000 on 03/13, 02/24 and 0 sales.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$VRTX Insider Trading Activity
$VRTX insiders have traded $VRTX stock on the open market 22 times in the past 6 months. Of those trades, 0 have been purchases and 22 have been sales.
Here’s a breakdown of recent trading of $VRTX stock by insiders over the last 6 months:
- RESHMA KEWALRAMANI (CEO & President) sold 15,198 shares for an estimated $7,826,970
- DAVID ALTSHULER (EVP, Chief Scientific Officer) has made 0 purchases and 7 sales selling 12,939 shares for an estimated $6,405,364.
- OURANIA TATSIS (EVP, Chief Reg. & Quality Off.) has made 0 purchases and 4 sales selling 7,854 shares for an estimated $3,844,667.
- EDWARD MORROW III ATKINSON (EVP, Chief Technical Ops. Off.) has made 0 purchases and 3 sales selling 6,164 shares for an estimated $2,912,812.
- JONATHAN BILLER (EVP and Chief Legal Officer) has made 0 purchases and 2 sales selling 5,090 shares for an estimated $2,332,768.
- CHARLES F JR WAGNER (EVP & Chief Financial Officer) sold 3,298 shares for an estimated $1,649,000
- KRISTEN AMBROSE (SVP & Chief Accounting Officer) has made 0 purchases and 3 sales selling 2,931 shares for an estimated $1,363,231.
- SANGEETA N. BHATIA sold 400 shares for an estimated $202,344
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$VRTX Hedge Fund Activity
We have seen 753 institutional investors add shares of $VRTX stock to their portfolio, and 761 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ALLIANCEBERNSTEIN L.P. removed 3,452,747 shares (-46.8%) from their portfolio in Q4 2024, for an estimated $1,390,421,216
- PARNASSUS INVESTMENTS, LLC added 1,815,950 shares (+inf%) to their portfolio in Q4 2024, for an estimated $731,283,065
- CAPITAL WORLD INVESTORS added 1,514,993 shares (+5.7%) to their portfolio in Q4 2024, for an estimated $610,087,681
- CAPITAL RESEARCH GLOBAL INVESTORS added 1,426,746 shares (+15.8%) to their portfolio in Q4 2024, for an estimated $574,550,614
- EDGEWOOD MANAGEMENT LLC added 1,410,238 shares (+91.2%) to their portfolio in Q4 2024, for an estimated $567,902,842
- FMR LLC removed 1,305,967 shares (-12.4%) from their portfolio in Q4 2024, for an estimated $525,912,910
- WELLINGTON MANAGEMENT GROUP LLP added 1,117,214 shares (+23.3%) to their portfolio in Q4 2024, for an estimated $449,902,077
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
